Regeneron Is Playing Defense With Capital Allocation
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
Emerson offers first look inside new Clayton HQ
Emerson Electric (NYSE: EMR), the St. Louis-based industrial technology and software company, unveiled its new corporate ...
Dezeen on MSN1d
Gensler to convert former Pfizer HQ into apartments in New York
American architecture studio Gensler has revealed designs for an office-to-residential conversion of the former Pfizer ...
How abandoned office buildings in L.A. could be transformed into $1,000 a month studio apartments
A new report from Gensler and the Pew Charitable Trust proposes converting old office buildings into SRO-style housing.
Le Lézard1d
MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...
Regeneron sees 2025 CapEx $850M-$975M
Sees 2025 non-GAAP R&D $5.00B-$5.20B. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Published first ...
Business Observer1d
MetLife's redone Tampa office aims to create a better workspace
The company's updated space is geared toward creating a more collaborative experience for workers and a place for the company ...